We interviewed Ilya Yasny, who is a luminary in the world of venture capitalism, particularly renowned for his role as a Partner at LanceBio VC, […]
Why you must consider your next investment into AI in Drug Discovery
Artificial intelligence (AI) is revolutionizing drug discovery by providing novel and efficient ways to identify potential therapeutic compounds. The process of discovering new drugs is […]
Venture Round – Causeway Sensors
On Mar 15, 2022 Causeway Sensors closed a Venture – Series Unknown round and raised £1,500,000 from Kernel Capital, QUBIS, featuring lead investors Kernel Capital. […]
Series B – Arima Genomics
On Mar 15, 2022 Arima Genomics closed a Series B round and raised $7,000,000 from Agilent Technologies, Berkeley Catalyst Fund (BCF), Cowin Venture, Genetron Health, […]
Series B – Molecular Assemblies
On Mar 15, 2022 Molecular Assemblies closed a Series B round and raised $25,800,000 from Agilent Technologies, Argonautic Ventures, Casdin Capital, Codexis, iSELECT FUND, LYFE […]
Series A – Eclipse Bioinnovations
On Mar 15, 2022 Eclipse Bioinnovations closed a Series A round and raised $14,000,000 from Alexandria Venture Investments, iGlobe, Phoenix Venture Partners, Photon Venture Alpha, […]
Venture Round – PrognomiQ
On Mar 15, 2022 PrognomiQ closed a Venture – Series Unknown round and raised $46,000,000 from aMoon Fund, Bruker, Catalio Capital Management, Emerson Collective, Fidelity […]
Seed Round – AiM Medical Robotics
On Mar 15, 2022 AiM Medical Robotics closed a Seed round and raised $3,400,000 from IQ Capital, Surrey Capital Partners, The Lambda Funds, Triple Ring […]
Venture Round – Causeway Sensors
On Mar 15, 2022 Causeway Sensors closed a Venture – Series Unknown round and raised £1,500,000 from Kernel Capital, QUBIS, featuring lead investors Kernel Capital. […]
Corporate Round – Emollivet
On Mar 15, 2022 Emollivet closed a Corporate Round round and raised SEK5,000,000 from Lipidor AB, featuring lead investors Lipidor AB. About the company: Emollivet […]
